Novartis Venture FundInvestor Details

Get alertedif Novartis Venture Fund makes an investment
Novartis Venture Fund
Key people
Reinhard AmbrosExecutive Director
Spyros Artavanis-tsakonasChairman, Option Fund
Markus GoebelManaging Director
Harry KirschChief Financial Officer
Campbell MurrayManaging Director
Raj ParekhGeneral Partnerr
Hidde PloeghDirector- Option Fund
Lauren SilvermanManaging Director
Want to know when Novartis Venture Fund invests in a new company?
Exo Therapeutics (2021: $78,000,000 raised)
Expansion Therapeutics (2021: $80,000,000 raised)
Gentibio (2021: $157,000,000 raised)
Artios Pharma (2021: $153,000,000 raised)
Tscan Therapeutics (2021: $100,000,000 raised)
Catalym Gmbh (2020: $66,210,000 raised)
Akouos (2020: $105,000,000 raised)
Adicet Bio Inc (2019: $80,000,000 raised)
Anokion Inc (2019: $40,000,000 raised)
Annexon Biosciences (2018: $75,000,000 raised)
Enterprise Therapeutics (2018: $41,000,000 raised)
Macrolide Pharmaceuticals Inc (2018: $20,000,000 raised)
Oculis (2018: $20,500,000 raised)
Expansion Therapeutics (2018: $55,300,000 raised)
Effector Therapeutics (2017: $45,000,000 raised)
Bicycle Therapeutics (2017: $52,000,000 raised)
Lemonaid Health (2017: $11,000,000 raised)
Vivet Therapeutics (2017: $49,657,500 raised)
Aerpio Pharmaceuticals (2017: $40,000,000 raised)
Cavion Llc (2017: $26,100,000 raised)
Inflazome (2016: $17,000,000 raised)
Annexon Biosciences (2016: $44,000,000 raised)
F2g Ltd (2016: $60,000,000 raised)
Galera Therapeutics (2016: $5,000,000 raised)
Adicet Bio Inc (2016: $51,000,000 raised)
Proteostasis Therapeutics (2015: $37,000,000 raised)
Ra Pharmaceuticals (2015: $58,500,000 raised)
Myopowers Medical Technologies France Sas (2015: $5,958,900 raised)
Autonomic Technologies Inc (2015: $38,000,000 raised)
Innocrin Pharmaceuticals (2015: $28,000,000 raised)
Nabriva Therapeutics Ag (2015: $120,000,000 raised)
Aeglea Biotherapeutics (2015: $44,000,000 raised)
Merganser Biotech Inc (2015: $28,000,000 raised)
Bionano Genomics Inc (2014: $53,000,000 raised)
Forendo Pharma (2014: $15,200,000 raised)
Bicycle Therapeutics (2014: $32,000,000 raised)
Thesan Pharmaceuticals Inc (2014: $49,000,000 raised)
Covagen Ag (2013: $47,100,000 raised)
Opsona Therapeutics Ltd (2013: $43,000,000 raised)
Gensight Biologics (2013: $42,000,000 raised)
Neurovance Inc (2012: $7,000,000 raised)
Ra Capital Management
New Enterprise Associates
Novo Ventures
5AM Ventures
Cormorant Asset Management
Correlation Ventures
Lilly Ventures
Satter Investment Management
Sr One Ltd
Surveyor Capital
Versant Ventures
6 Dimensions Capital
Alexandria Venture Investments
Amgen Ventures
Atlas Venture
Avidity Partners
Ecor1 Capital
Edmond de Rothschild Investment Partners
Enso Ventures Ltd
Fountain Healthcare Partners
Kleiner Perkins
Longwood Fund
Osage University Partners
Pivotal Bioventure Partners
Pontifax Ltd
Roche Venture Fund
Rock Springs Capital
Sanofi Ventures
Sectoral Asset Management
Seroba Kernel Life Sciences
Sunstone Capital
Sv Life Sciences
415 Ventures
A&b Equity Holdings
Abbvie Biotech Ventures
Aberdare Ventures
Abingworth Llp
Adage Capital Partners Lp
Adaptive Healthcare Fund
Advent Life Sciences
Advent Life Sciences Llp
Aisling Capital
Ally Bridge Group
Altitude Life Science Ventures
Amoon2 Fund
Andera Partners
Arix Bioscience Plc
Astellas Ventures
Bain Capital Life Sciences
Battelle Ventures
Baxter Ventures
Bb Biotech Ventures
Bessemer Venture Partners
Biogeneration Ventures
Biomed Ventures
Biomedical Ventures
Blackrock Inc
Blackstone Life Sciences
Boxer Capital Llc
Brace Pharma Capital
Brunnur Ventures
Bvf Partners
Caas Capital Management
Cambridge Innovation Capital (cic)
Casdin Capital
Cleveland Clinic
Columbus Venture Partners
Cowen Healthcare Investments
Cowen Investments
Deep Track Capital
Domain Associates
Elan Science One
Embl Ventures
Epidarex Capital
Eshelman Ventures
Fidelity Biosciences
Fidelity Management & Research Company
Forbion Capital Partners
Frazier Healthcare
Galera Angels
Gran Plasa
Gund Investment Corp
Gurnet Point Capital
Hatteras Venture Partners
HealthCare Ventures
Hikma Ventures
Index Ventures
InterWest Partners
Intersouth Partners
Ip Group
Ip Group Plc
Jdrf T1d Fund
Jennison Associate
Johnson & Johnson Innovation
Kearny Venture Partners
Kleiner Perkins Caufield And Byers
Kurma Partners
Legend Capital
Lightstone Ventures Lp
Limulus Venture Partners
Logos Capital
Lsp (life Sciences Partners)
Lundbeckfond Ventures
M Ventures
Matrix Capital Management
Merifin Capital
Mission Bay Capital Llc
Morgenthaler Ventures
Mp Healthcare Venture Management
Ms Ventures
New Enterprise Associates (nea
New Enterprise Associates (nea)
New Investors Sv Life Sciences
Newpath Partners
Nextech Invest Ltd
Novartis Bioventures
Novartis Venture Funds Inc
Novo A/S
Omega Funds
Orbimed Israel Partners
Pagsgroup Surveyor Capital
Partners Innovation Fund
Pfizer Venture Investments
Pfizer Venture Investments (pvi)
Pfizer Ventures
Phase4 Partners
Piper Heartland Healthcare Capital
Pitango Healthtech
Polaris Founders Fund
Quest Diagnostics
Roche Ventures
Rock Springs Capital Management
Rtw Investments
Samsara Biocapital
Sanofi-genzyme Bioventures
Schroders Capital
Sofinnova Investments
Sofinnova Partners
Soleus Capital
Sutter Hill Ventures
Sv Health Investors
Tcg X
Tetragon Financial Group Ltd
The Column Group
Triathlon Medical Ventures
Truffle Capital
U.s Venture Partners
Ut Horizon Fund
Vega Ventures
Ventech Et Mp Healthcare Venture Management Inc
Venture Investors Llc
Vertex Ventures Hc
Vesalius Biocapital Iii
Vivo Capital
Wachstumsfonds Bayern
Wellcome Trust
Westlake Village Biopartners
Wu Capital
Ysios Capital
This list displays investors that took part in the same funding round as Novartis Venture Fund since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!